Alpharma Preps For NSAID Patch Launch One Year After Approval
Alpharma is gearing up for the launch of the first non-steroidal anti-inflammatory patch, Flector Patch, during the second week of January, one year after FDA approved the drug. Flector Patch is approved for the topical treatment of acute pain due to minor strains, sprains and contusions
You may also be interested in...
The US FDA appears to have concerns about the device used to administer the vaccine.
Revlimid, Copaxone, Sensipar, Enbrel, Acthar Gel and Gleevec will be the subject of a US House Committee on Oversight and Reform in an upcoming drug price hearing.
Pfizer was heavily invested in immuno-oncology combinations five years ago, but following setbacks, the pipeline has shifted considerably, shaped partly by the acquisition of Array.